Does CARMUSTINE Cause Diffuse large b-cell lymphoma recurrent? 63 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with CARMUSTINE (carmustine). This represents 1.9% of all adverse event reports for CARMUSTINE.
63
Reports of Diffuse large b-cell lymphoma recurrent with CARMUSTINE
1.9%
of all CARMUSTINE reports
15
Deaths
18
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From CARMUSTINE?
Of the 63 reports, 15 (23.8%) resulted in death, 18 (28.6%) required hospitalization, and 4 (6.3%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARMUSTINE. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does CARMUSTINE Cause?
Off label use (454)
Febrile neutropenia (297)
Myelodysplastic syndrome (295)
Disease progression (241)
Acute myeloid leukaemia (180)
Thrombocytopenia (174)
Pyrexia (152)
Drug ineffective (149)
Mucosal inflammation (148)
Second primary malignancy (141)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which CARMUSTINE Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
CARMUSTINE vs CARTEOLOL
CARMUSTINE vs CARVEDILOL
CARMUSTINE vs CASIMERSEN
CARMUSTINE vs CASIRIVIMAB
CARMUSTINE vs CASIRIVIMAB\IMDEVIMAB